1. Pourhaji F, Peyman N, Taraghdar MM, Jamali J, Tehrani H. Explaining the burden of psychosocial factors on the worsening symptoms of MS: a qualitative study of patients' experiences. BMC Neurology. 2023;23(1). [DOI:10.1186/s12883-023-03148-z] [PMID] []

2. Solaro C, Ponzio M, Moran E, et al. The changing face of multiple sclerosis: Prevalence and incidence in an aging population. Mult Scler Relat Disord. 2015;21(10):1244-1250. [DOI:10.1177/1352458514561904] [PMID]

3. McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA. 2021;325(8):765-779. [DOI:10.1001/jama.2020.26858] [PMID]

4. Abbastabar H, Bitarafan S, Mohammadpour Z, Mohammadianinejad SE, Harirchian MH. The trend of incidence, prevalence, and DALY of multiple sclerosis in the Middle East and Northern Africa region compared to global, West Europe and, Iran's corresponding values during 1990-2017: Retrieved from global burden of diseases data. Mult Scler Relat Disord. 2021;52:102949. [DOI:10.1016/j.msard.2021.102949] [PMID]

5. Barcaccia B, Esposito G, Matarese M, Bertolaso M, Elvira M, De Marinis MG. Defining Quality of Life: A Wild-Goose Chase?. EJOP. 2013;9(1):185-03. [DOI:10.5964/ejop.v9i1.484]

6. Kes VB, Cengić L, Cesarik M, et al. Quality of life in patients with multiple sclerosis. Acta Clin Croat. 2013;52(1):107-111.

7. Lin X, Zhang X, Liu Q, et al. Social cognition in multiple sclerosis and its subtypes: A meta-analysis. Mult Scler Relat Disord. 2021;52:102973. [DOI:10.1016/j.msard.2021.102973] [PMID]

8. Pitteri M, Romualdi C, Magliozzi R, Monaco S, Calabrese M. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Mult Scler Relat Disord. 2017;23(6):848-854. [DOI:10.1177/1352458516665496] [PMID]

9. Sumowski JF, Benedict R, Enzinger C, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology. 2018;90(6):278-288. [DOI:10.1212/WNL.0000000000004977] [PMID] []

10. Niino M, & Miyazaki Y. Cognitive impairment as one of the important non- motor symptoms in multiple sclerosis and neuromyelitis optica spectrum disorders. Wiley online Library. 2019; 10(3):152-160. [DOI:10.1111/cen3.12528]

11. Kurtz MM, Richardson CL. Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research. Schizophr Bull. 2012;38(5):1092-1104. [DOI:10.1093/schbul/sbr036] [PMID] []

12. Cotter J, Firth J, Enzinger C, et al. Social cognition in multiple sclerosis: A systematic review and meta-analysis. Neurology. 2016;87(16):1727-1736. [DOI:10.1212/WNL.0000000000003236] [PMID] []

13. Chalah MA, Ayache SS. A Scope of the Social Brain in Multiple Sclerosis: Insights From Neuroimaging Studies. Cogn Behav Neurol. 2020;33(2):90-102. [DOI:10.1097/WNN.0000000000000227] [PMID]

14. Simmons RD. Life issues in multiple sclerosis. Nat Rev Neurol. 2010;6(11):603-610. [DOI:10.1038/nrneurol.2010.143] [PMID]

15. McCabe PJ, Barnason SA. Illness perceptions, coping strategies, and symptoms contribute to psychological distress in patients with recurrent symptomatic atrial fibrillation. J Cardiovasc Nurs. 2012;27(5):431-444. [DOI:10.1097/JCN.0b013e31821e7ab1] [PMID]

16. Obiwuru O, Joseph S, Liu L, et al. Perceptions of Multiple Sclerosis in Hispanic Americans: Need for Targeted Messaging. Int J MS Care. 2017;19(3):131-139. [DOI:10.7224/1537-2073.2015-081] [PMID] []

17. Smedema SM. An analysis of the relationship of character strengths and quality of life in persons with multiple sclerosis. Qual Life Res. 2020;29(5):1259-1270. [DOI:10.1007/s11136-019-02397-1] [PMID]

18. Pollock SE. The hardiness characteristic: a motivating factor in adaptation. ANS Adv Nurs Sci. 1989;11(2):53-62. [DOI:10.1097/00012272-198901000-00009] [PMID]

19. Contrada RJ. Type A behavior, personality hardiness, and cardiovascular responses to stress. J Pers Soc Psychol. 1989;57(5):895-903. [DOI:10.1037/0022-3514.57.5.895] [PMID]

20. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001;124(Pt 5):962-973. [DOI:10.1093/brain/124.5.962] [PMID]

21. McGuigan C, Hutchinson M. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry. 2004;75(2):266-269

22. Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler. 2003;9(4):411-419. [DOI:10.1191/1352458503ms929oa] [PMID]

23. Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry. 2002;73(6):701-704. [DOI:10.1136/jnnp.73.6.701] [PMID] []

24. Ayatollahi P, Nafisi Sh, MSIS-29 Questionnaire in Iranian MS patients, Validity and Reliability. J TMU. 2007; 64(1): 62-68.

25. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631-637. [DOI:10.1016/j.jpsychores.2005.10.020] [PMID]

26. Torshabi M, Bahrami ehsan H.The comparison hardiness between chronic patients & normal people. Psychol J. 2009;14(4):338-356.

27. Katebi M, Sepahmansoor M. Comparison of Heath Hardiness and Life Expectancy in patients with Diabetes and Breast cancer. Health psychol. 2019; 8(3):155-168.

28. AliakbariDehkordi M, Bitaneh M. The Effectiveness of Psychological Capital Elements Training on Psychological Flexibility and Psychological Distress on the Women with Breast Cancer. Health Psychol. 2021;10(38): 7-22.

29. Bitaneh M, Zare H, Alizadehfard S, Erfani N. The Effect of Social Cognition and Interaction Training on Facial Emotion Recognition in the Elderly with Mild Cognitive Impairment. J Salmand. 2022;17(3):446-459.

30. Davari, A & Rezazadeh, A. Structural Equation Modeling with PLS. 2nd.Tehran: Jahade Daneshgahi Pub;2018.

31. Bassi M, Falautano M, Cilia S, et al. Illness Perception and Well-Being Among Persons with Multiple Sclerosis and Their Caregivers. J Clin Psychol Med Settings. 2016;23(1):33-52. [DOI:10.1007/s10880-015-9425-8] [PMID]

32. Spain LA, Tubridy N, Kilpatrick TJ, Adams SJ, Holmes AC. Illness perception and health-related quality of life in multiple sclerosis. Acta Neurol Scand. 2007;116(5):293-299. [DOI:10.1111/j.1600-0404.2007.00895.x] [PMID]

33. Zahraie SH, Amini SH, Saebi S.Relationship between disease perception, stigma experience and cognitive fusion with the quality of life of women with multiple sclerosis. Psych Studies. 2018; 14(2):25-40. doi: 10.22051/psy.2018.21294.1687.

34. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome. Eur J Endocrinol. 2011;165(4):527-535. [DOI:10.1530/EJE-11-0307] [PMID]

35. Lerdal A, Celius EG, Moum T. Perceptions of illness and its development in patients with multiple sclerosis: a prospective cohort study. J Adv Nurs. 2009;65(1):184-192. [DOI:10.1111/j.1365-2648.2008.04862.x] [PMID]

36. Yusefi KH, Zagham hajebi M, Saravani SH. Prediction of tendency towards suicidal thoughts based on psychological toughness and perceived body image in patients with multiple sclerosis. Health Psych. 2021;10(39):157-170.

37. Yusefi afrashteh M, Golmohammadi F, Tamjidi N. Path analysis of the mediating role of life expectancy in the relationship between psychological toughness and the ability to tolerate ambiguity with death anxiety in patients with MS. Med J mums. 2020;63(5):2768-2778.

38. Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin. Exp Immunol. 2014;176(2):149-164. [DOI:10.1111/cei.12271] [PMID] []

39. Kobasa SC, Maddi SR & Kahn S. Hardiness and health: A prospective study. J Pers Soc Psychol. 1982;42(1):168-177. [DOI:10.1037/0022-3514.42.1.168] [PMID]

40. Lin X, Zhang X, Liu Q, et al. Social cognition in multiple sclerosis and its subtypes: A meta-analysis. Mult Scler Relat Disord. 2021;52:102973. [DOI:10.1016/j.msard.2021.102973] [PMID]

41. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7(12):1139-1151. [DOI:10.1016/S1474-4422(08)70259-X] [PMID]

42. Bora E, Özakbaş S, Velakoulis D, Walterfang M. Social Cognition in Multiple Sclerosis: a Meta-Analysis. Neuropsychol Rev. 2016;26(2):160-172. [DOI:10.1007/s11065-016-9320-6] [PMID]

43. Uekermann J, Kraemer M, Abdel-Hamid M, et al. Social cognition in attention-deficit hyperactivity disorder (ADHD). Neurosci Biobehav Rev. 2010;34(5):734-743. [DOI:10.1016/j.neubiorev.2009.10.009] [PMID]

44. Benedict RH, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231(1-2):29-34. [DOI:10.1016/j.jns.2004.12.009] [PMID]

45. Goldman A, de Vignemont F. Is social cognition embodied?. Trends Cogn Sci. 2009;13(4):154-159. [DOI:10.1016/j.tics.2009.01.007] [PMID]

46. Yaghoti F, Motamed S. Recognition of facial emotional states using brain emotional learning model. ICSS J. 2017; 20(4):46-61.

47. Bonanno GA. Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events?. Am Psychol. 2004;59(1):20-28. [DOI:10.1037/0003-066X.59.1.20] [PMID]

48. Brooks MV. Health-related hardiness and chronic illness: a synthesis of current research. Nurs Forum. 2003;38(3):11-20. [DOI:10.1111/j.0029-6473.2003.00011.x] [PMID]

49. Ciampi E, Uribe-San-Martin R, Vásquez M, et al. Relationship between Social Cognition and traditional cognitive impairment in Progressive Multiple Sclerosis and possible implicated neuroanatomical regions. Mult Scler Relat Disord. 2018;20:122-128. [DOI:10.1016/j.msard.2018.01.013] [PMID]